1. Market Research
  2. > Therapy
41 reports for Salicylic Acid (page 1)

Purchase Reports From Reputable Market Research Publishers

Non-opioid Pain Patches Market-Global Industry Analysis and Opportunity Assessment, 2020-2030

  • $ 5000
  • April 2020
  • 195 pages

Methyl Salicylate Patches ##. ##. ##.

  • Opioid
  • Salicylic Acid
  • Therapy
  • World
  • Market Size

Drug of Abuse Testing Market (By Product Type, Sample/Test Type, End Users / Setting Type, Region), Regulatory Status, 20 Company Profiles – Global Forecast to 2025

  • $ 1990
  • January 2020
  • 150 pages

Opiate Oxycodone Phencyclidine Propoxyphene Salicylate Synthetic Cannabinoid K-##/ K-## (Restricted in the U. S. to law enforcement related use (forensic use only)).

  • Diagnostics
  • Drug Testing
  • Opioid
  • Salicylic Acid
  • World

Non-opioid Pain Patch Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

  • $ 5795
  • June 2017
  • 163 pages

Methyl Salicylate Patches ##. ##. ##.

  • Opioid
  • Pharmaceutical
  • Salicylic Acid
  • Therapy
  • World

Global Drug of Abuse Testing Market (By Product Type, Sample/Test Type, End Users / Setting Type, Region), Regulatory Status, 20 Company Profile – Forecast to 2024

  • $ 1600
  • October 2018
  • 142 pages

Medical tests for toxicology and drugs of abuse are usually done as a panel on overdose and trauma patients brought into emergency and include: a screen for alcohol, acetaminophen, salicylates, tricyclic antidepressants and individual tests for amitriptyline, amphetamines, barbiturates, ben

  • Drug Testing
  • Laboratory
  • Opioid
  • Salicylic Acid
  • World

Non-Opioid Drugs for Chronic Pain and Pain Management Devices Market, 2018-2025

  • $ 3499
  • August 2018
  • 340 pages

Roots Analysis: According to you, what is the opportunity for non-opioid analgesics?

  • Chronic Pain
  • Opioid
  • Salicylic Acid
  • North America
  • United States

Global Cancer Pain Therapeutics Market 2015-2019

  • $ 2500
  • January 2016
  • 61 pages

Non-opioids analgesics are classified into short- and long-acting pain medications.

  • Cancer
  • Opioid
  • Salicylic Acid
  • Therapy
  • BioDelivery Sciences International, Inc.

PRESCRIPTION PAIN DRUGS–INCLUDING OPIOID, ANTICONVULSANT, INJECTABLE/INHALED, TOPICAL/TRANSDERMAL, MEDICAL MARIJUANA–GLOBAL MARKETS, COMPETITORS AND OPPORTUNITIES: 2015-2020 ANALYSIS AND FORECASTS

  • $ 2400
  • September 2015
  • 283 pages

NSAIDS SHOULD BE AVOIDED IN PATIENTS KNOWN TO HAVE THIS ASPIRIN--SENSITIVITY.

  • Analgesic
  • Marijuana
  • Opioid
  • Pharmaceutical
  • Salicylic Acid

Global Pain Management Market Report: 2015 Edition

  • $ 800
  • December 2015
  • 55 pages

The non-opioid analgesics include NSAIDs, steroidal antiinflammatories, local anesthetics, alpha-## agonists, acetaminophen, ketamine and COX inhibitors.

  • Analgesic
  • Chronic Pain
  • Opioid
  • Salicylic Acid
  • Pfizer Inc.

Cancer Pain - Pipeline Review, H2 2019

  • $ 2000
  • December 2019
  • 148 pages

The company develops a new class of non-opioid analgesics utilizing its proprietary platform technology TTX (Tetrodotoxin or TTX).

  • Analgesic
  • Biopharmaceutical
  • Cancer
  • Opioid
  • Pharmaceutical

Cancer Pain - Pipeline Review, H1 2020

  • $ 2000
  • May 2020
  • 155 pages

The company is developing a new class of non-opioid analgesics by utilizing its proprietary platform technology TTX (Tetrodotoxin or TTX).

  • Biopharmaceutical
  • Cancer
  • Opioid
  • Pharmaceutical
  • Salicylic Acid

PharmSource - Contract Small Molecule API Manufacturing Industry by the Numbers - 2019 Edition

  • $ 4995
  • August 2019
  • 44 pages

Numerous bills such as the Opioid Crisis Response Act of 2018 have been introduced in the US to support the development and FDA approval of non-opioid analgesics.

  • Opioid
  • Pharmaceutical
  • United States
  • World
  • Company Operations

Peripheral Neuropathic Pain Global Clinical Trials Review, H1, 2020

  • $ 2500
  • June 2020
  • 470 pages

Peripheral Neuropathic Pain Global Clinical Trials Review, H1, 2020 Summary Clinical trial report, “Peripheral Neuropathic Pain Global Clinical Trials Review, H1, 2020" provides an overview of Peripheral ...

  • Chronic Pain
  • Clinical Trial
  • Neurology
  • Opioid
  • Salicylic Acid

Back Pain Global Clinical Trials Review, H1, 2020

  • $ 2500
  • January 2020
  • 609 pages

Aspirin Cardio-coated Tablets (Enteric Coated Bayer Bitterfeld Gmbh, Germany) An Open, Randomized, Cross-over Study of Comparative Pharmacokinetics and Bioequivalence of Drugs Acetylsalicylic Acid Cardio-coated Tablets, ## Mg (Oao Tatkhimpharmpreparaty, Russia) and Aspirin Cardio-

  • Chronic Pain
  • Clinical Trial
  • Opioid
  • Pharmaceutical
  • Salicylic Acid

Anesthetic Effect - Pipeline Review, H1 2020

  • $ 2000
  • March 2020
  • 97 pages

Baudax Bio, Inc announced its launch as an independent, publicly traded pharmaceutical company focused on advancing non-opioid analgesics and other products for the hospital and other acute care settings.

  • Opioid
  • Pharmaceutical
  • Salicylic Acid
  • Therapy
  • PAION AG

Back Pain Global Clinical Trials Review, H2, 2020

  • $ 2500
  • July 2020
  • 626 pages

Aspirin Cardio-coated Tablets (Enteric Coated Bayer Bitterfeld Gmbh, Germany) An Open, Randomized, Cross-over Study of Comparative Pharmacokinetics and Bioequivalence of Drugs Acetylsalicylic Acid Cardio-coated Tablets, ## Mg (Oao Tatkhimpharmpreparaty, Russia) and Aspirin Cardio-

  • Chronic Pain
  • Clinical Trial
  • Opioid
  • Pharmaceutical
  • Salicylic Acid

Substance (Drug) Abuse Global Clinical Trials Review, H2, 2019

  • $ 2500
  • December 2019
  • 651 pages

Aspirin Inhibition of COX-## Derived PGE## in Male Smokers Low Dose Aspirin Inhibition of COX-## Derived PGE## in Male Smokers GDCT## NCT##, VR## Central Nervous System Nicotine Addiction, Substance (Drug) Abuse (Prostaglandin E## (PGE##), Prostaglandin G/ H Synthase ## (

  • Clinical Trial
  • Opioid
  • Pharmaceutical
  • Salicylic Acid
  • Therapy

Nociceptin Receptor - Pipeline Review, H1 2020

  • $ 3500
  • April 2020
  • 52 pages

The invention relates to methods and compositions for treatment of pain via craniofacial mucosal administration of an analgesic compound (e. g. a non-opioid analgesic peptide, an NOP agonist or N/ OFQ).

  • Analgesic
  • Chronic Pain
  • Opioid
  • Therapy
  • World

Post-Operative Pain - Pipeline Review, H1 2020

  • $ 2000
  • January 2020
  • 295 pages

In this study, the researchers conducted a network meta-analysis (NMA) assessing the safety and efficacy of IV meloxicam relative to other IV non-opioid analgesics for moderate to severe pain.

  • Analgesic
  • Opioid
  • Pharmaceutical
  • Salicylic Acid
  • Therapy

KemPharm Inc (KMPH) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • October 2018
  • 56 pages

Chemically, Asal-HM (KP##) is a conjugate of hydromorphone and two acetylsalicylic acid (aspirin) moieties.

  • Neurological Disorder
  • Opioid
  • Pharmaceutical
  • Salicylic Acid
  • KemPharm, Inc.

Opioids Market - Growth, Trends, and Forecast (2019-2024)

  • $ 4250
  • April 2019
  • 147 pages

There are non-opioid drugs posing a threat of external substitution, namely, ibuprofen, aspirin, and steroids.

  • Opioid
  • Salicylic Acid
  • Therapy
  • North America
  • United States
View report >

Opioid Market in the US

  • January 2018
  • 163 pages

Table ##. ## shows trends in the claim frequency of pain medications, overall, and separately for claims that received opioids only, both opioid and non-opioid analgesics, and non-opioid analgesics only.

  • Analgesic
  • Opioid
  • Salicylic Acid
  • Therapy
  • United States

Opioid Market October 2018

Opioid Market in France February 2019

Opioid Market in the UK September 2019

Opioid Market in the UK September 2019

Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on